Life ScienceCompany
Alexion Pharmaceuticals M&A Summary
Alexion Pharmaceuticals has acquired 9 companies of its own, including 3 in the last 5 years. A total of 1 acquisition came from private equity firms.
Alexion Pharmaceuticals’ largest acquisition to date was in 2015, when it acquired Synageva BioPharma for $8.4B. Alexion Pharmaceuticals has acquired in 3 different US states, and 3 countries. The Company’s most targeted sectors include life science (89%) and healthcare services (12%).
Alexion Pharmaceuticals Ownership
Who owns Alexion Pharmaceuticals?
Alexion Pharmaceuticals is owned by AstraZeneca. It was acquired on December 12, 2020.
Alexion Pharmaceuticals Business Overview
Where is Alexion Pharmaceuticals headquartered?
Alexion Pharmaceuticals is headquartered in Boston, Connecticut.
What is Alexion Pharmaceuticals’ revenue?
Alexion Pharmaceuticals disclosed revenue of 6,070M USD for 2020 and 4,991M USD for 2019.
How many employees does Alexion Pharmaceuticals have?
Alexion Pharmaceuticals has 3,082 employees.
What sector is Alexion Pharmaceuticals in?
Alexion Pharmaceuticals is a life science company.
When was Alexion Pharmaceuticals founded?
Alexion Pharmaceuticals was founded in 1992.
M&A Summary
-
M&A Total Activity9
- M&A Buy Activity9
- Total Sectors Invested 2
- Total Countries Invested 3
- M&A Buy/Sell Connections 1
- M&A Advisors 10
Unlimited Searches
